Register to chat with like-minded investors on our interactive forums.

Get Started

TXG

10x Genomics (TXG)

10x Genomics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TXG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Date	Time	Source	Headline	Symbol	Company
11/16/2023	4:22PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
11/06/2023	4:05PM	PR Newswire (US)	OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study	NASDAQ:TXG	10x Genomics Inc
11/02/2023	4:05PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXG	10x Genomics Inc
11/02/2023	4:05PM	PR Newswire (US)	10x Genomics Reports Third Quarter 2023 Financial Results	NASDAQ:TXG	10x Genomics Inc
11/01/2023	4:05PM	PR Newswire (US)	10x Genomics to Present at the Stephens 25th Annual Conference	NASDAQ:TXG	10x Genomics Inc
10/26/2023	4:05PM	PR Newswire (US)	Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain Tumors	NASDAQ:TXG	10x Genomics Inc
10/18/2023	4:33PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
10/11/2023	4:05PM	PR Newswire (US)	10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023	NASDAQ:TXG	10x Genomics Inc
10/10/2023	12:06PM	PR Newswire (US)	10x Genomics Comments on Second UPC Preliminary Injunction Decision	NASDAQ:TXG	10x Genomics Inc
09/19/2023	1:08PM	PR Newswire (US)	10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe	NASDAQ:TXG	10x Genomics Inc
09/18/2023	4:43PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
09/14/2023	5:15PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
09/14/2023	4:36PM	PR Newswire (US)	10x Genomics Expands Gene Expression Flex Offering with New High-Throughput Multiomic Profiling Kit	NASDAQ:TXG	10x Genomics Inc
09/05/2023	9:00AM	PR Newswire (US)	Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others	NASDAQ:TXG	10x Genomics Inc
08/30/2023	4:05PM	PR Newswire (US)	10x Genomics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference	NASDAQ:TXG	10x Genomics Inc
08/29/2023	4:30PM	PR Newswire (US)	10x Genomics Surpasses 100 Xenium Analyzer Shipments	NASDAQ:TXG	10x Genomics Inc
08/24/2023	5:11PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
08/24/2023	5:09PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
08/24/2023	5:08PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
08/24/2023	5:08PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
08/16/2023	5:11PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
08/03/2023	4:23PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
08/03/2023	4:05PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXG	10x Genomics Inc
08/03/2023	4:05PM	PR Newswire (US)	10x Genomics Reports Second Quarter 2023 Financial Results	NASDAQ:TXG	10x Genomics Inc
07/21/2023	5:32PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
07/21/2023	5:31PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
07/21/2023	2:21PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
07/20/2023	4:05PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXG	10x Genomics Inc
07/18/2023	6:26PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
07/13/2023	4:05PM	PR Newswire (US)	10x Genomics to Report Second Quarter 2023 Financial Results on August 3, 2023	NASDAQ:TXG	10x Genomics Inc

Showing the most relevant articles for your search:NASDAQ:TXG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Northwest Biotherapeutics (QB)

Ethema Health (PK)

Asia Broadband (PK)

1812 Brewing (PK)

Kraig Biocraft Laborator... (QB)

Faraday Future Intellige...

Bioelectronics (PK)

Fannie Mae (QB)

SMC Entertainment (PK)

Digital Brand Media and ... (PK)

Anavex Life Sciences

Emergent Health (PK)

Delayed Upgrade Clock